Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0007 Transporter Info | ||||
| Gene Name | SLC47A1 | ||||
| Protein Name | Multidrug and toxin extrusion protein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs2252281 | ||||
| Site of GPD | chr17:19533874 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | T>C | ||||
| Minor Allele Frequency | C=0.3035/1520 (Global) | ||||
| Allele C | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Metformin | Drug Info | Polycystic Ovary Syndrome | Irrelevant to the drug response in patients (compare with Allele T) | [ 1] | |
| Genotype CC | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
| Metformin | Drug Info | Healthy Individuals | Correlated with the increased drug response in healthy individuals (compare with Genotypes CT + TT) | [ 2] | |
| Metformin | Drug Info | Diabetes Mellitus | Correlated with the increased drug response in patients (compare with Genotypes CT + TT) | [ 2] | |
| Genetic Polymorphism | rs2289669 | ||||
| Site of GPD | chr17:19560030 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | G>A | ||||
| Minor Allele Frequency | A=0.3552/1779 (Global) | ||||
| Allele A | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
| Metformin | Drug Info | Diabetes Mellitus | Irrelevant to the drug response in patients (compare with Allele G) | [ 3] | |
| Metformin | Drug Info | Polycystic Ovary Syndrome | Irrelevant to the drug response in patients (compare with Allele G) | [ 1] | |
| Genotype AA | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Metformin | Drug Info | Diabetes Mellitus | Correlated with the increased drug response in patients (compare with genotypes AG + GG) | [ 4], [ 5] | |
| Genotype GG | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Metformin | Drug Info | Diabetes Mellitus | Correlated with the increased drug response in patients (compare with genotypes AA + AG) | [ 6] | |
| References | |||||
| 1 | The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial. Basic Clin Pharmacol Toxicol. 2018 Feb;122(2):239-244. | ||||
| 2 | The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. Clin Pharmacol Ther. 2013 Feb;93(2):186-94. | ||||
| 3 | Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis. Clin Pharmacol Ther. 2017 Jun;101(6):763-772. | ||||
| 4 | Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes. Diabetes Obes Metab. 2013 Feb;15(2):189-91. | ||||
| 5 | SLC47A1 gene rs2289669 G>A variants enhance the glucose-lowering effect of metformin via delaying its excretion in Chinese type 2 diabetes patients. Diabetes Res Clin Pract. 2015 Jul;109(1):57-63. | ||||
| 6 | The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.